Literature DB >> 19222724

Chronic kidney disease-mineral and bone disorder (CKD-MBD): a new term for a complex approach.

Frantisek Svára1.   

Abstract

The global widespread of the chronic kidney disease (CKD) is a worldwide health problem. Its increasing incidence and prevalence and adverse outcomes (including decreased quality of life, increased morbidity and mortality) represents a huge challenge for all recent health are systems. Reflecting this situation, the new, global initiative (KDIGO) was established to enhance communication and clinical decision-making, promote the use of evidence based medicine and facilitate clinical research. The new definition, evaluation and classification of "renal osteodystrophy"; has been one of the first outcome of this initiative, suggesting the topic of chronic kidney disease--mineral and bone disorder (CKD-MBD) to be a hot problem of recent nephrology. The new terminology is consistent with a recent view on this topic and describes CKD-MBD as a complex syndrome, including abnormal mineral and PTH metabolism, altered bone structure as far as extra-skeletal calcifications.

Entities:  

Mesh:

Year:  2009        PMID: 19222724     DOI: 10.1111/j.1755-6686.2009.00067.x

Source DB:  PubMed          Journal:  J Ren Care        ISSN: 1755-6678


  2 in total

1.  Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.

Authors:  M Ota; M Takahata; T Shimizu; Y Kanehira; H Kimura-Suda; Y Kameda; H Hamano; S Hiratsuka; D Sato; N Iwasaki
Journal:  Osteoporos Int       Date:  2016-12-08       Impact factor: 4.507

2.  PTH hypersecretion triggered by a GABAB1 and Ca2+-sensing receptor heterocomplex in hyperparathyroidism.

Authors:  Wenhan Chang; Chia-Ling Tu; Frederic G Jean-Alphonse; Amanda Herberger; Zhiqiang Cheng; Jenna Hwong; Hanson Ho; Alfred Li; Dawei Wang; Hongda Liu; Alex D White; Insoo Suh; Wen Shen; Quan-Yang Duh; Elham Khanafshar; Dolores M Shoback; Kunhong Xiao; Jean-Pierre Vilardaga
Journal:  Nat Metab       Date:  2020-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.